To evaluate the accuracy and completeness of surgeon reported radical prostatectomy outcome data across a national health system by comparison with a national dataset gathered independently from clinicians directly involved in patient care.
To systematically review the most recent evidence on the role of surgery in patients with urothelial carcinoma of bladder and lymph node metastasis. Patients with urothelial carcinoma of bladder and lymph node metastasis have a poor prognosis.
This study aimed to ascertain gene expression profile differences between progressive muscle-invasive bladder cancer (MIBC) and de novo MIBC, and to identify prognostic biomarkers to improve patients’ treatment.
Unplanned visits (UPV) – re-admissions and emergency room (ER) visits – are markers of healthcare system quality. Radical prostatectomy (RP) is a commonly performed cancer procedure, where variation in UPV represents a gap in care for prostate cancer patients.
(UroToday.com) Focus groups and interviews of 11 women, mean age 61 years (range 39-88), were conducted to understand patient experiences regarding mid-urethral sling (MUS) surgery and outcomes. Discussions were recorded and transcribed and transcripts were coded to reflect themes and illustrative quotations. Concerns voiced by these women revolved around 5 themes: healthcare experience, decision making, endorsement […]
(UroToday.com) Clinical hypnosis is an intervention used to support the management of chronic pain and illness and there is some data to suggest that it can reduce urinary frequency. This is an interesting study as it involved 8-session hypnosis treatment in patients (n=74) with chronic pain from diffuse musculoskeletal pain to rheumatologic, urologic, and neuropathic pain. […]
Small cell carcinoma of the bladder (SCCB) is a rare, aggressive non-urothelial histologic variant of bladder cancer. Large-scale clinical data evaluating the various management approaches and outcomes are limited.
Phase III VISION study with 177Lu-PSMA-617 met both primary endpoints, significantly improving overall survival (OS) and radiographic progression-free survival (rPFS) in patients with PSMA-positive metastatic castration-resistant prostate cancer1 VISION trial findings to be presented at upcoming medical meeting, with regulatory submissions in the US and EU anticipated in 2021 Novartis is committed to reimagining prostate cancer […]
To investigate the impact of high-intensity local treatment (LT) on overall survival (OS) in patients with stage IV upper tract urothelial carcinoma (UTUC). Within the National Cancer Database, we identified 7,357 patients diagnosed with stage IV UTUC from 2004 to 2015.
Studies evaluating the association between peripheral blood leukocyte telomere length and testicular germ cell tumor (TGCT) risk have produced conflicting results. Using available genotype data from the Testicular Cancer Consortium (TECAC), polygenic risk score (PRS) and mendelian randomization (MR) analyses of genetic variants previously associated with leukocyte telomere length were used to assess potential etiologic […]
